What is SAR analysis?
Structural Analysis Relationship (SAR) analysis evaluates how the chemical structure of compounds, particularly those with similar functional groups like benzene rings, relates to their biological functions by binding to target molecules and inducing conformational changes, enabling drug development through iterative modification, bioinformatics analysis, and experimental validation to identify and optimize lead compounds with desired therapeutic properties.
Structural Analysis Relationship (SAR) analysis is the evaluation of the relationship between the structure of chemical compounds, of interest to medicine, to their biological functions in the body. SAR analysis is especially significant in drug development since it enables the discovery of novel drugs to treat diseases.
Molecular compounds with the same core functional groups, such as the benzene double rings in antibiotics, have more or less similar biological functions. Such molecular compounds work by binding specific active sites in target biological molecules, such as receptors of cells, leading to a conformational change of the latter. This conformational change alters some biological function in the biological pathway that the target molecule is involved in.
These molecular compounds can then be tweaked by removing or adding chemical ligands to modify their chemistry and hence also affect their function in the body. Several modified molecules, also called hits in drug discovery, are then analyzed using bioinformatics tools and then by biological experiments such as microarrays, to ascertain a lead compound. The lead compound is then further modified to achieve the best-desired properties, and the final compound is then used in making drugs.
Usually, to find potent molecular/chemical compounds for a particular biological function, data mining in biological databases is conducted and hits are then analyzed using bioinformatics tools to reach a lead compound. The function of these structural hits can even be predicted by analyzing their structure and comparing them to other known compounds of similar structure or functional groups. Experiments are then performed to validate what was postulated. Experiments are significant since they enable scientists to ascertain aspects such as thermodynamics, pharmacokinetics, side effects/toxicity, stereochemistry, and elimination of the compounds.
Today, novel chemical compounds can be drawn on computers using computer models that work on data from biological databases. These novel compounds can then be synthesized from scratch and analyzed.
Related
FAQ center
The FAQ center explains that lab automation uses data science to create intelligent systems reducing human input, digital labs fully digitize operations for efficiency, future labs will heavily rely on robotics and integrated data management, lab compliance ensures safe and effective lab practices, data integrity ensures reliable data quality, scientific data management systems (SDMS) facilitate safe and accessible scientific data handling, and open data differs from FAIR data in accessibility and usability requirements.
What is hit to lead stage in drug discovery?
The hit-to-lead (H2L) stage in drug discovery involves refining initial chemical hits with desired therapeutic effects by synthesizing, testing, and optimizing compounds through methods like structure-activity relationships, computational modeling, and high-throughput screening to identify and improve lead candidates with enhanced potency, specificity, and drug-like properties for further development.
How are small molecule drugs developed?
Small molecule drugs, typically organic compounds with low molecular weight that easily penetrate cells, are developed through interdisciplinary methods such as rational drug design, natural source isolation, phenotypic screening, and target-based drug discovery, and are widely used in medicinal applications including novel cancer therapies and RNA-targeting biochemical regulation.
Reasonable Expectations, Clean Data, Collaboration: The Three Keys to AI in Drug Discovery
The article explains that while AI and machine learning have long been used in drug discovery, recent hype and massive investments have led to unrealistic expectations, emphasizing that success depends on setting reasonable goals, ensuring clean and abundant data, and fostering collaboration, as most AI-driven drug candidates remain in early development stages and face complex biological and practical challenges.
Data Management, Collaboration, and Workflow Optimisation: The Three Keys to Small Molecule Discovery Success
The article emphasizes that despite biologics' prominence, small molecule drug discovery is experiencing a renaissance driven by advances in screening, target exploration, and AI, but overcoming challenges like rising costs, data management, fragmented workflows, and CRO reliance requires success in three key areas: next-generation data management, enhanced cross-disciplinary research collaboration, and workflow optimization.
What is structure-activity relationship (SAR)?
The structure-activity relationship (SAR) describes how a molecule's chemical structure influences its biological activity, enabling researchers in drug discovery to identify key chemical groups responsible for effects, predict activities of new compounds based on structural similarities, and optimize drug development through data analysis and visualization tools like Dotmatics that facilitate efficient SAR analysis and molecular modeling.